Katherine S. Pawelczak

ORCID: 0000-0002-2099-2858

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction”.

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction

Nucleic Acids Research(2020)10.1093/nar/gkaa934

N/A

0DataRank · unranked

48 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Pamela L Mendoza-Munoz, Tyler L. Vernon, Leslyn A. Hanakahi +8 more

Discovery and Development of Novel DNA-PK Inhibitors by Targeting the unique Ku-DNA Interaction

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.261875

N/A

0DataRank · unranked

4 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Tyler L. Vernon, Leslyn A. Hanakahi, Matthew Summerlin +7 more

Chemical exhaustion of RPA in cancer treatment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.30.404640

N/A

0DataRank · unranked

4 citations

Katherine S. Pawelczak, Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci +4 more

OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy

Cancers(2021)10.3390/cancers13133346

N/A

0DataRank · unranked

13 citations

Sofia Vaides, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Jason A. Stewart, John J. Turchi +1 more

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Frontiers in Oncology(2022)10.3389/fonc.2022.850883

N/A

0DataRank · unranked

24 citations

Amirreza Samarbakhsh, Athira Pillai, Pamela S. VanderVere-Carozza, Hariprasad Aruri, Deepti S. Pandey +4 more

In Vivo Targeting Replication Protein A for Cancer Therapy

Frontiers in Oncology(2022)10.3389/fonc.2022.826655

N/A

0DataRank · unranked

23 citations

Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci, Joshua Heyza +5 more

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases

Frontiers in Oncology(2022)10.3389/fonc.2022.1023500

N/A

0DataRank · unranked

1 citations

Katherine S. Pawelczak, Michael Weinfeld, Peter J. McHugh, John J. Turchi

Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks

NAR Cancer(2023)10.1093/narcan/zcad003

N/A

0DataRank · unranked

8 citations

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Joseph R. Dynlacht, Joy Garrett +2 more

Targeting DNA damage sensors for cancer therapy

DNA repair(2025)10.1016/j.dnarep.2025.103841

N/A

0DataRank · unranked

3 citations

Pamela L. Mendoza-Munoz, Katherine S. Pawelczak, John J. Turchi, Matthew R. Jordan

Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.09.647957

N/A

0DataRank · unranked

0 citations

Matthew R. Jordan, Joy Garrett, Karen E. Pollok, Hilary D. Hinshaw, Xierzhatijiang Sulaiman +5 more